Co-Diagnostics awarded additional grant for tuberculosis test

Co-Diagnostics announced a grant awarded by the Bill & Melinda Gates Foundation to support the tuberculosis test in development, designed to be run on the upcoming Co-Dx PCR platform. The amount awarded is $8.976 million. The Company’s TB test, which Co-Dx has designed for afflicted markets worldwide highly burdened by the disease, will be applied towards regulatory and clinical validation activities, increasing manufacturing capacity, and additional platform software development. The grant will leverage the existing infrastructure and manufacturing capabilities of Co-Diagnostics’ joint venture in India, CoSara Diagnostics. Those assets will be enhanced and expanded to help meet the anticipated demand for testing once the Co-Dx PCR platform, including the associated TB test, is available.